Publications by authors named "G A Alper"
Background: Hemoglobin A1c (HbA1c) levels play an important role in diagnosing, screening, and monitoring the treatment of diabetes. Our study aims to determine whether a relationship exists between HbA1c levels and age and gender in Turkish adults who have not been diagnosed with diabetes.
Methods: This retrospective study included 6776 Turkish adults with no known diabetes.
Sotos syndrome is a non-progressive neurological disease with overgrowing, increased bone age, and developmental retardation. The aim of this study is to evaluate the prenatal, natal, and postnatal clinical findings of patients with Sotos syndrome. Sixteen patients suspected to have Sotos syndrome with clinical findings were examined retrospectively, ranging in ages between 3 and 23.
View Article and Find Full Text PDFAim: We used magnetic resonance imaging (MRI) to compare the neuroimaging of children with their first episode of clinical enterovirus 71-associated transverse myelitis (EV71-TM), myelin oligodendrocyte glycoprotein antibody positive transverse myelitis (MOG-TM), aquaporin-4 antibody positive transverse myelitis (AQP4-TM), transverse myelitis in multiple sclerosis (MS-TM), and unclassified transverse myelitis (UNC-TM).
Method: We performed a retrospective blinded radiological assessment and compared the neuroimaging of 52 children (32 females, 20 males; mean age 9y 8mo, SD 5y 5mo, range 5mo-17y) presenting with their first episode of myelitis caused by EV71-TM (n=11), MOG-TM (n=10), AQP4-TM (n=9), MS-TM (n=13), and UNC-TM (n=9).
Results: In the EV71-TM group, lesions were distributed throughout the cord and enhancement of nerve roots (ventral and dorsal) was common.
The clinicaltrials.gov identifying number for the article titled "Impact of an electronic monitoring device and behavioral feedback on adherence to multiple sclerosis therapies in youth: results of a randomized trial" is NCT02234713 (https://clinicaltrials.gov/ct2/show/NCT02234713).
View Article and Find Full Text PDFArticle Synopsis
- This study evaluated the safety and effectiveness of the Medos Deltastream DP3 ECLS system for pediatric cardiac patients, analyzing 102 cases from March 2011 to April 2016, with a focus on patient outcomes and complications.
- The shift from the DP2 to the DP3 system led to improved weaning rates from ECLS support (70.3% post-switch vs. 36% pre-switch) and a significant decrease in mechanical complications (9% for DP3 vs. 32% for DP2).
- Survivors' median ECLS duration was 8.2 days, and complications like renal and neurologic issues were linked to lower hospital discharge rates, while elevated lact